Skip to content
Markets
SPY700.39▼ -2.16%QQQ620.55▼ -3.80%DIA486.91▼ -0.79%GLD322.89▼ -3.67%TLT81.30▲ +1.18%BABA82.67▼ -0.76%NIO2.50▼ -6.20%PDD84.97▼ -1.20%Realtime derived data
Octans ResearchOCTANS RESEARCHWaitlist
The Lower Manhattan skyline at dusk seen across the East River, One World Trade Center at center.
Source: Superbass, CC BY-SA 4.0, via Wikimedia Commons

bioAffinity Technologies 10% owner Hrt Financial Lp buys $1.0 million of shares

Open market purchase reported on Form 4, filed Nov 19, 2026.

Octans ResearchPublished

Snapshot

Hrt Financial Lp, a holder of more than 10% of the shares of bioAffinity Technologies (BIAF), bought 138,244 shares in open market purchases between Sep 22, 2026 and Oct 1, 2026, about $1.0 million at an average price of $7.52 a share, according to a Form 4 filed with the SEC on Nov 19, 2026.

Coverage
Independent Research
Prepared by
Octans Research
Tickers
BIAF
As of

Market Data

Latest prices for the companies covered in this article
Company1D %Price
($BIAF)▼ −6.49%1.73

as of 12:41 ET · Realtime derived data

What We Know

The filing lists 11 open market purchase lines: • Sep 22, 2026: 18,929 shares at $8.59. • Sep 23, 2026: 7,509 shares at $7.91. • Sep 23, 2026: 11,002 shares at $8.14. • Sep 24, 2026: 30,065 shares at $7.67. • Sep 25, 2026: 7,271 shares at $7.81. • Sep 28, 2026: 10,734 shares at $7.64. • Sep 28, 2026: 2 shares at $8.09. • Sep 29, 2026: 8,894 shares at $6.86. • Plus 3 more purchase lines in the filing.

After the last purchase, the filing reports 116,658 shares held directly in that account.

Octans View

An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought.

Bear Case · Room for Disagreement

Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.

Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.

Chart

$BIAF adjusted close, last 6 months $BIAF adjusted close, last 6 months: series falling from 24.8 to 1.9 (−92.5%) from 2026-05-26 to 2026-11-19. Scale 0 to 30. 0102030 2026-05-262026-11-19 $BIAF ADJUSTED CLOSE, LAST 6 MONTHS −92.5% 1.85
Source: Tiingo · As of 2026-11-19Indicative, not investment advice.

Sources

  1. [1]SEC EDGAR — Form 4 filed by Hrt Financial Lp for bioAffinity Technologies, Nov 19, 2026

These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.

$1.0M

Hrt Financial Lp, a holder of more than 10% of the shares of bioAffinity Technologies (BIAF), b… · Snapshot

Related coverage

More on $BIAF

4 reports